Загрузка...
Safety and Efficacy in Relapsed or Refractory Classic Hodgkin's Lymphoma Treated with PD-1 Inhibitors: A Meta-Analysis of 9 Prospective Clinical Trials
BACKGROUND: Classic Hodgkin's lymphoma (cHL) is characterized by the unique biology in which rare Hodgkin-Reed-Sternberg cells propagate an immunosuppressive microenvironment. Checkpoint inhibitors that target the interaction of PD-1 immune checkpoint receptors have demonstrated remarkable acti...
Сохранить в:
| Опубликовано в: : | Biomed Res Int |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6948280/ https://ncbi.nlm.nih.gov/pubmed/31950058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/9283860 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|